Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2007-01-31
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thyroid Dysfunction and Dyslipidemia in Patients With Chronic Kidney Diseases
NCT03277911
Urotensin II in Chronic Kidney Diseases and Kidney Transplants
NCT01098799
Chemoreflex Sensitivity in Chronic Kidney Disease
NCT00794872
Prevention of Acute Kidney Injury - Molecular Mechanisms of Dietary Pre-conditioning in Human
NCT02745444
Cohort Follow-up: Progression and Consequences of Chronic Kidney Disease.
NCT04070885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with chronic kidney disease stage 3
No interventions assigned to this group
patients with chronic kidney disease stage 4
No interventions assigned to this group
patients with chronic kidney disease stage 5 (ESRD)
No interventions assigned to this group
Controls (no kidney disease)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Charite UNiversity Medicine Berlin, Germany
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Petra Reinke, Md PhD
Role: PRINCIPAL_INVESTIGATOR
Charite University Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite University Medicine Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRY1STU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.